霍乱

Sack DA, Sack RB, Nair GB, et al. Cholera. Lancet. 2004;363:223-233.

• 摘要

Harris JB, LaRocque RC, Qadri F, et al. Cholera. Lancet. 2012;379:2466-2476.

• 摘要

Das JK, Tripathi A, Ali A, et al. Vaccines for the prevention of diarrhea due to cholera, shigella, ETEC and rotavirus. BMC Public Health. 2013;13(suppl 3):S11.

• 全文
• 摘要

Bhattacharya SK, Sur D, Ali M, et al. 5 year efficacy of a bivalent killed whole-cell oral cholera vaccine in Kolkata, India: a cluster-randomised, double-blind, placebo-controlled trial. Lancet Infect Dis. 2013;13:1050-1056.

• 摘要

Ali M, Sur D, You YA, et al. Herd protection by a bivalent killed whole-cell oral cholera vaccine in the slums of Kolkata, India. Clin Infect Dis. 2013;56:1123-1131.

• 全文
• 摘要

Leibovici-Weissman Y, Neuberger A, Bitterman R, et al. Antimicrobial drugs for treating cholera. Cochrane Database Syst Rev. 2014;(6):CD008625.

• 全文
• 摘要

Nelson EJ, Nelson DS, Salam MA, et al. Antibiotics for both moderate and severe cholera. N Engl J Med. 2011;364:5-7.

• 全文
• 摘要

1.  Sack DA, Sack RB, Nair GB, et al. Cholera. Lancet. 2004;363:223-233.

• 摘要

2.  Siddique AK, Nair GB, Alam M, et al. El Tor cholera with severe disease: a new threat to Asia and beyond. Epidemiol Infect. 2010;138:347-352.

• 摘要

3.  World Health Organization. Cholera fact sheet. http://www.who.int/ (last accessed 5 July 2017).

• 全文

4.  Diop SA, Manga NM, Dia NM, et al. Cholera and pregnancy: epidemiological, clinical, and evolutionary aspects [in French]. Med Mal Infect. 2007;37:816-820.

• 摘要

5.  World Health Organization. Weekly epidemiological record. September 2016. http://www.who.int/ (last accessed 5 July 2017).

• 全文

6.  Ali M, Lopez AL, You YA, et al. The global burden of cholera. Bull World Health Organ. 2012;90:209-218A.

• 全文
• 摘要

7.  Ali M, Nelson AR, Lopez AL, et al. Updated global burden of cholera in endemic countries. PLoS Negl Trop Dis. 2015;9:e0003832.

• 摘要

8.  Emch M, Feldacker C, Islam MS, et al. Seasonality of cholera from 1974 to 2005: a review of global patterns. Int J Health Geogr. 2008;7:31.

• 全文
• 摘要

9.  World Health Organization. Statement from UNICEF Executive Director Anthony Lake and WHO Director-General Margaret Chan on the cholera outbreak in Yemen as suspected cases exceed 200 000. June 2017. http://www.who.int/ (last accessed 5 July 2017).

• 全文

10.  Griffith DC, Kelly-Hope LA, Miller MA. Review of reported cholera outbreaks worldwide, 1995-2005. Am J Trop Med Hyg. 2006;75:973-977.

• 全文
• 摘要

11.  Zuckerman JN, Rombo L, Fisch A. The true burden and risk of cholera: implications for prevention and control. Lancet Infect Dis. 2007;7:521-530.

• 摘要

12.  Cholera, 2007. Wkly Epidemiol Rec. 2008;83:269-283.

• 摘要

13.  Mahalanabis D, Faruque AS, Albert MJ, et al. An epidemic of cholera due to Vibrio cholerae O139 in Dhaka, Bangladesh: clinical and epidemiological features. Epidemiol Infect. 1994;112:463-471.

• 摘要

14.  Morris JG Jr. Cholera and other types of vibriosis: a story of human pandemics and oysters on the half shell. Clin Infect Dis. 2003;37:272-280.

• 全文
• 摘要

15.  Holbourn KP, Shone CC, Acharya KR. A family of killer toxins: exploring the mechanism of ADP-ribosylating toxins. FEBS J. 2006;273:4579-4593.

• 全文
• 摘要

16.  Paneth N. Assessing the contributions of John Snow to epidemiology: 150 years after removal of the broad street pump handle. Epidemiology. 2004;15:514-516.

• 摘要

17.  Ries AA, Vugia DJ, Beingolea L, et al. Cholera in Piura, Peru: a modern urban epidemic. J Infect Dis. 1992;166:1429-1433.

• 摘要

18.  Motarjemi Y, Käferstein F, Moy G, et al. Contaminated weaning food: a major risk factor for diarrhoea and associated malnutrition. Bull World Health Organ. 1993;71:79-92.

• 全文
• 摘要

19.  Gundry S, Wright J, Conroy R. A systematic review of the health outcomes related to household water quality in developing countries. J Water Health. 2004;2:1-13.

• 摘要

20.  Wright J, Gundry S, Conroy R. Household drinking water in developing countries: a systematic review of microbiological contamination between source and point-of-use. Trop Med Int Health. 2004;9:106-117.

• 全文
• 摘要

21.  Rabbani GH, Greenough WB 3rd. Food as a vehicle of transmission of cholera. J Diarrhoeal Dis Res. 1999;17:1-9.

• 摘要

22.  Albert MJ. Epidemiology and molecular biology of Vibrio cholerae O139 Bengal. Indian J Med Res. 1996;104:14-27.

• 摘要

23.  Hashizume M, Wagatsuma Y, Faruque AS, et al. Factors determining vulnerability to diarrhoea during and after severe floods in Bangladesh. J Water Health. 2008;6:323-332.

• 摘要

24.  Evans CA, Gilman RH, Rabbani GH, et al. Gastric acid secretion and enteric infection in Bangladesh. Trans R Soc Trop Med Hyg. 1997;91:681-685.

• 摘要

25.  Nalin DR, Levine RJ, Levine MM, et al. Cholera, non-vibrio cholera, and stomach acid. Lancet. 1978;2:856-859.

• 摘要

26.  Berger SA, Young NA, Edberg SC. Relationship between infectious diseases and human blood type. Eur J Clin Microbiol Infect Dis. 1989;8:681-689.

• 摘要

27.  Cohen MB, Giannella RA, Losonsky GA, et al. Validation and characterization of a human volunteer challenge model for cholera by using frozen bacteria of the new Vibrio cholerae epidemic serotype, O139. Infect Immun. 1999;67:6346-6349.

• 全文
• 摘要

28.  Harris JB, Khan AI, LaRocque RC, et al. Blood group, immunity, and risk of infection with Vibrio cholerae in an area of endemicity. Infect Immun. 2005;73:7422-7427.

• 全文
• 摘要

29.  Palmer DL, Koster FT, Alam AK, et al. Nutritional status: a determinant of severity of diarrhea in patients with cholera. J Infect Dis. 1976;134:8-14.

• 摘要

30.  von Seidlein L, Wang XY, Macuamule A, et al. Is HIV infection associated with an increased risk for cholera? Findings from a case-control study in Mozambique. Trop Med Int Health. 2008;3:683-688.

• 全文
• 摘要

31.  Witt VM, Reiff FM. Environmental health conditions and cholera vulnerability in Latin America and the Caribbean. J Public Health Policy. 1991;12:450-463.

• 摘要

32.  Sinclair D, Abba K, Zaman K, et al. Oral vaccines for preventing cholera. Cochrane Database Syst Rev. 2011;(3):CD008603.

• 全文
• 摘要

33.  Saha A, Chowdhury MI, Khanam F, et al. Safety and immunogenicity study of a killed bivalent (O1 and O139) whole-cell oral cholera vaccine Shanchol, in Bangladeshi adults and children as young as 1 year of age. Vaccine. 2011;29:8285-8292.

• 摘要

34.  Sur D, Kanungo S, Sah B, et al. Efficacy of a low-cost, inactivated whole-cell oral cholera vaccine: results from 3 years of follow-up of a randomized, controlled trial. PLoS Negl Trop Dis. 2011;5:e1289.

• 全文
• 摘要

35.  Phares CR, Date K, Travers P, et al. Mass vaccination with a two-dose oral cholera vaccine in a long-standing refugee camp, Thailand. Vaccine. 2016;34:128-133.

• 全文
• 摘要

36.  Qadri F, Ali M, Chowdhury F, et al. Feasibility and effectiveness of oral cholera vaccine in an urban endemic setting in Bangladesh: a cluster randomised open-label trial. Lancet. 2015;386:1362-1371.

• 摘要

37.  Harris JB, LaRocque RC, Qadri F, et al. Cholera. Lancet. 2012;379:2466-2476.

• 摘要

38.  Clemens JD, Nair GB, Ahmed T, et al. Cholera. Lancet. 2017 Mar 10 [Epub ahead of print].

• 全文
• 摘要

39.  Hill DR, Ford L, Lalloo DG. Oral cholera vaccines: use in clinical practice. Lancet Infect Dis. 2006;6:361-373.

• 摘要

40.  Sur D, Lopez AL, Kanungo S, et al. Efficacy and safety of a modified killed-whole-cell oral cholera vaccine in India: an interim analysis of a cluster-randomised, double-blind, placebo-controlled trial. Lancet. 2009;374:1694-1702.

• 摘要

41.  Masuet Aumatell C, Ramon Torrell JM, Zuckerman JN. Review of oral cholera vaccines: efficacy in young children. Infect Drug Resist. 2011;4:155-160.

• 全文
• 摘要

42.  Das JK, Tripathi A, Ali A, et al. Vaccines for the prevention of diarrhea due to cholera, shigella, ETEC and rotavirus. BMC Public Health. 2013;13(suppl 3):S11.

• 全文
• 摘要

43.  Bhattacharya SK, Sur D, Ali M, et al. 5 year efficacy of a bivalent killed whole-cell oral cholera vaccine in Kolkata, India: a cluster-randomised, double-blind, placebo-controlled trial. Lancet Infect Dis. 2013;13:1050-1056.

• 摘要

44.  World Health Organization. Cholera vaccines: WHO position paper - Recommendations. Vaccine. 2010;28:4687-4688.

• 摘要

45.  Martin S, Lopez AL, Bellos A, et al. Post-licensure deployment of oral cholera vaccines: a systematic review. Bull World Health Organ. 2014;92:881-893.

• 全文
• 摘要

46.  Ali M, Sur D, You YA, et al. Herd protection by a bivalent killed whole-cell oral cholera vaccine in the slums of Kolkata, India. Clin Infect Dis. 2013;56:1123-1131.

• 全文
• 摘要

47.  Wong KK, Burdette E, Mahon BE, et al. Recommendations of the Advisory Committee on Immunization Practices for Use of Cholera Vaccine. MMWR Morb Mortal Wkly Rep. 2017;66:482-485.

• 摘要

48.  Chen WH, Cohen MB, Kirkpatrick BD, et al. Single-dose live oral cholera vaccine CVD 103-HgR protects against human experimental infection with Vibrio cholerae O1 El Tor. Clin Infect Dis. 2016;62:1329-1335.

• 全文
• 摘要

49.  Graves PM, Deeks JJ, Demicheli V, et al. Vaccines for preventing cholera: killed whole cell or other subunit vaccines (injected). Cochrane Database Syst Rev. 2010;(8):CD000974.

• 全文
• 摘要

50.  Vugia DJ, Rodriguez M, Vargas R, et al. Epidemic cholera in Trujillo, Peru 1992: utility of a clinical case definition and shift in Vibrio cholerae O1 serotype. Am J Trop Med Hyg. 1994;50:566-569.

• 摘要

51.  Swerdlow DL, Ries AA. Cholera in the Americas. Guidelines for the clinician. JAMA. 1992;267:1495-1499.

• 摘要

52.  Sack DA, Tacket CO, Cohen MB, et al. Validation of a volunteer model of cholera with frozen bacteria as the challenge. Infect Immun. 1998;66:1968-1972.

• 全文
• 摘要

53.  Kaushik JS, Gupta P, Faridi MM, et al. Single dose azithromycin versus ciprofloxacin for cholera in children: a randomized controlled trial. Indian Pediatr. 2010;47:309-315.

• 摘要

54.  Chatterjee A, Mahalanabis D, Jalan KN, et al. Plasma specific gravity and haematocrit values as indices of the degree of dehydration in infantile diarrhoea. Indian J Med Res. 1979;70:229-232.

• 摘要

55.  Cook GC. Gastroenterological emergencies in the tropics. Baillieres Clin Gastroenterol. 1991;5:861-886.

• 摘要

56.  Wang F, Butler T, Rabbani GH, et al. The acidosis of cholera. Contributions of hyperproteinemia, lactic acidemia, and hyperphosphatemia to an increased serum anion gap. N Engl J Med. 1986;315:1591-1595.

• 摘要

57.  Mandell, GL, Bennett JE, Dolin R. Mandell, Douglas, and Bennett's principles and practice of infectious diseases. 6th ed. New York, NY: Elsevier/Churchill Livingstone; 2005.

58.  Nato F, Boutonnier A, Rajerison M, et al. One-step immunochromatographic dipstick tests for rapid detection of Vibrio cholerae O1 and O139 in stool samples. Clin Vaccine Immunol. 2003;10:476-478.

• 全文
• 摘要

59.  Ramamurthy T, Pal A, Bag PK, et al. Detection of cholera toxin gene in stool specimens by polymerase chain reaction: comparison with bead enzyme-linked immunosorbent assay and culture method for laboratory diagnosis of cholera. J Clin Microbiol. 1993;31:3068-3070.

• 全文
• 摘要

60.  Mundy LS, Shanholtzer CJ, Willard KE, et al. An evaluation of three commercial fecal transport systems for the recovery of enteric pathogens. Am J Clin Pathol. 1991;96:364-367.

• 摘要

61.  Harris JR, Cavallaro EC, de Nobrega AA, et al. Field evaluation of crystal VC(R) rapid dipstick test for cholera during a cholera outbreak in Guinea-Bissau. Trop Med Int Health. 2009;114:1117-1121.

• 摘要

62.  Centers for Disease Control and Prevention. Laboratory methods for the diagnosis of epidemic dysentery and cholera. 1999. http://www.cdc.gov/ (last accessed 5 July 2017).

• 全文

63.  Shirai H, Nishibuchi M, Ramamurthy T, et al. Polymerase chain reaction for detection of the cholera enterotoxin operon of Vibrio cholerae. J Clin Microbiol. 1991;29:2517-2521. [Erratum in: J Clin Microbiol. 1992;30:1620.]

• 全文
• 摘要

64.  Khuntia HK, Pal BB, Chhotray GP. Quadruplex PCR for simultaneous detection of serotype, biotype, toxigenic potential, and central regulating factor of Vibrio cholerae. J Clin Microbiol. 2008;46:2399-2401.

• 全文
• 摘要

65.  Yamazaki W, Seto K, Taguchi M, et al. Sensitive and rapid detection of cholera toxin-producing Vibrio cholerae using a loop-mediated isothermal amplification. BMC Microbiol. 2008;8:94.

• 全文
• 摘要

66.  Saha D, Karim MM, Khan WA, et al. Single-dose azithromycin for the treatment of cholera in adults. N Engl J Med. 2006;354:2452-2462.

• 全文
• 摘要

67.  Weil AA, Khan AI, Chowdhury F, et al. Clinical outcomes in household contacts of patients with cholera in Bangladesh. Clin Infect Dis. 2009;49:1473-1479.

• 全文
• 摘要

68.  Faruque AS, Mahalanabis D, Islam A, et al. Common diarrhea pathogens and the risk of dehydration in young children with acute watery diarrhea: a case-control study. Am J Trop Med Hyg. 1993;49:93-100.

• 摘要

69.  Alam M, Hasan NA, Sultana M, et al. Diagnostic limitations to accurate diagnosis of cholera. J Clin Microbiol. 2010;48:3918-3922.

• 摘要

70.  WHO Global Task Force on Cholera Control. Acute diarrhoeal diseases in complex emergencies: critical steps. 2010. http://www.who.int/ (last accessed 5 July 2017).

• 全文

71.  Musekiwa A, Volmink J. Oral rehydration salt solution for treating cholera: <= 270 mOsm/L solutions vs >= 310 mOsm/L solutions. Cochrane Database Syst Rev. 2011;(12):CD003754.

• 全文
• 摘要

72.  Roy SK, Islam A, Ali R, et al. A randomized clinical trial to compare the efficacy of erythromycin, ampicillin and tetracycline for the treatment of cholera in children. Trans R Soc Trop Med Hyg. 1998;92:460-462.

• 摘要

73.  Kabir I, Khan WA, Haider R, et al. Erythromycin and trimethoprim-sulphamethoxazole in the treatment of cholera in children. J Diarrhoeal Dis Res. 1996;14:243-247.

• 摘要

74.  Leibovici-Weissman Y, Neuberger A, Bitterman R, et al. Antimicrobial drugs for treating cholera. Cochrane Database Syst Rev. 2014;(6):CD008625.

• 全文
• 摘要

75.  Nelson EJ, Nelson DS, Salam MA, et al. Antibiotics for both moderate and severe cholera. N Engl J Med. 2011;364:5-7.

• 全文
• 摘要

76.  Alam AN, Alam NH, Ahmed T, et al. Randomised double blind trial of single dose doxycycline for treating cholera in adults. BMJ. 1990;300:1619-1621.

• 全文
• 摘要

77.  Khan WA, Bennish ML, Seas C, et al. Randomised controlled comparison of single-dose ciprofloxacin and doxycycline for cholera caused by Vibrio cholerae O1 or O139. Lancet. 1996;348:296-300.

• 摘要

78.  Roy SK, Hossain MJ, Khatun W, et al. Zinc supplementation in children with cholera in Bangladesh: randomised controlled trial. BMJ. 2008;336:266-268.

• 全文
• 摘要

79.  Canani RB, Cirillo P, Buccigrossi V, et al. Zinc inhibits cholera toxin-induced, but not Escherichia coli heat-stable enterotoxin-induced, ion secretion in human enterocytes. J Infect Dis. 2005;191:1072-1077.

• 全文
• 摘要

80.  World Health Organization. Vitamin A supplementation in infants and children 6–59 months of age. 2011. www.who.int/ (last accessed 5 July 2017).

• 全文

81.  Ghana VAST Study Team. Vitamin A supplementation in northern Ghana: effects on clinic attendances, hospital admissions, and child mortality. Lancet. 1993;342:7-12.

• 摘要

82.  Bhandari N, Bahl R, Sazawal S, et al. Breast-feeding status alters the effect of vitamin A treatment during acute diarrhea in children. J Nutr. 1997;127:59-63.

• 全文
• 摘要

83.  Imdad A, Mayo-Wilson E, Herzer K, et al. Vitamin A supplementation for preventing morbidity and mortality in children from six months to five years of age. Cochrane Database Syst Rev. 2017;3:CD008524.

• 摘要

84.  Utsalo SJ, Eko FO, Umoh F, et al. Faecal excretion of Vibrio cholerae during convalescence of cholera patients in Calabar, Nigeria. Eur J Epidemiol. 1999;15:379-381.

• 摘要

85.  Echevarría J, Seas C, Carrillo C, et al. Efficacy and tolerability of ciprofloxacin prophylaxis in adult household contacts of patients with cholera. Clin Infect Dis. 1995;20:1480-1484.

• 摘要

86.  Reveiz L, Chapman E, Ramon-Pardo P, et al. Chemoprophylaxis in contacts of patients with cholera: systematic review and meta-analysis. PLoS One. 2011;6:e27060.

• 全文
• 摘要